FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 72 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $338,000 | -85.1% | 67,429 | -82.1% | 0.98% | +68.4% |
| Q4 2017 | $2,268,000 | -11.8% | 377,397 | -18.5% | 0.58% | -7.8% |
| Q3 2017 | $2,572,000 | -2.6% | 463,297 | -18.6% | 0.63% | -3.4% |
| Q2 2017 | $2,641,000 | -7.2% | 569,197 | -1.0% | 0.65% | -9.8% |
| Q1 2017 | $2,845,000 | -53.5% | 574,797 | +4.3% | 0.72% | -55.5% |
| Q4 2016 | $6,116,000 | -99.9% | 550,997 | +5.3% | 1.62% | +29.4% |
| Q3 2016 | $4,846,656,000 | +27.5% | 523,397 | -12.5% | 1.25% | +51.3% |
| Q2 2016 | $3,799,821,000 | -63.6% | 598,397 | -62.6% | 0.83% | -60.0% |
| Q1 2016 | $10,425,682,000 | -14.2% | 1,599,031 | +6.8% | 2.07% | +53.3% |
| Q4 2015 | $12,144,165,000 | +91.7% | 1,497,431 | +73.2% | 1.35% | +46.4% |
| Q3 2015 | $6,336,111,000 | +87282.6% | 864,408 | +22.2% | 0.92% | -25.9% |
| Q2 2015 | $7,251,000 | +37.9% | 707,449 | +24.4% | 1.24% | -2.9% |
| Q1 2015 | $5,259,000 | +46.3% | 568,549 | +10.9% | 1.28% | +21.7% |
| Q4 2014 | $3,594,000 | – | 512,649 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|